共 88 条
[1]
Donze J(2012)Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study Am J Med 125 1095-1102
[2]
Rodondi N(2009)Hemostasis and thrombosis in older adults J Thromb Thrombolysis 27 249-251
[3]
Waeber G(2022)ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Eur Heart J 43 3826-3924
[4]
Monney P(2022)2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC) Rev Esp Cardiol (Engl Ed) 75 429-279
[5]
Cornuz J(2018)The impact of aging on cardio and cerebrovascular diseases Int J Mol Sci 19 481-340
[6]
Aujesky D(2017)Guideline for stopping anticoagulants prior to urological procedures J Clin Urol 11 271-2615
[7]
Gharacholou SM(2007)Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study Scand J Urol Nephrol 41 335-1363
[8]
Becker RC(2009)Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder J Urol 181 2608-1833
[9]
Halvorsen S(2007)Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity J Urol 178 1359-723
[10]
Mehilli J(2021)Intravesical onabotulinumtoxinA injections in patients on antiplatelet and anticoagulation therapy Neurourol Urodyn 40 1829-328